Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) Financials

CELC

Celcuity Inc
10.25
-0.105 (-1.01%)
Upgrade to Real-Time

Celcuity Inc. (CELC) Fundamentals
Celcuity Inc is a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications. The company's therapeutic candidate is gedatolisib, a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all Class I isoforms of PI3K and the mammalian target of rapamycin (mTOR).
SHARE INFORMATION
Market Cap$ 224,593,996
Shares Outstanding21,689,425
Float17,309,593
Percent Float79.81%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.64
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions124
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months1,803,808
Institutional Holdings Percent57.7%
Institutional Sold Previous 3 Months1,136,748
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months449,694
Insider Holdings Percent20.3
Insider Sold Previous 3 Months271,903
Insider Shares Owned4,407,216
TRADING INFO
52 Week High$ 14.40
52 Week Low$ 4.81
52 Week High Change$ 18.21
21 Day Moving Average$ 10.6745
21 Day Extended Moving Average$ 10.5763
50 Day Moving Average$ 10.8792
50 Day Extended Moving Average$ 10.7864
200 Day Moving Average$ 10.1147
200 Day Extended Moving Average$ 10.5878
10 Day Average Volume129,955
20 Day Average Volume108,470
30 Day Average Volume84,338
50 Day Average Volume68,912
Alpha0.013331
Beta0.6294
Standard Deviation0.247173
R20.018806
7 Day Price Change$ 0.295
7 Day Percent Change2.93%
21 Day Price Change$ -0.945
21 Day Percent Change-8.36%
30 Day Price Change$ -1.43
30 Day Percent Change-12.1%
Month to Date Price Change$ -1.43
Month to Date Percent Change-12.1%
Quarter to Date Price Change$ -3.66
Quarter to Date Percent Change-26.09%
180 Day Price Change$ 0.315
180 Day Percent Change3.14%
200 Day Price Change$ 1.34
200 Day Percent Change14.93%
Year to Date Price Change$ -3.66
Year to Date Percent Change-26.09%

Celcuity Inc. (CELC) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.70
Total Debt To Equity0.30
Int Coverage-18.20
Current Ratio25.50
Leverage Ratio1.30
Quick Ratio24.50
Long Term Debt To Capital0.21
VALUATION MEASURES
PE Ratio-4.90
Enterprise Value$ 90,269,855
Price to Sales0.00
Price to Free Cash-6.20
PE High Last 5 Years-6.50
Price To Book1.70
Price To Cash Flow0.00
PE Low Last 5 Years-17.60
Price to Tangible Book1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-30.86
Return on Equity-39.88
Return on Capital-46.03

Celcuity Inc. (CELC) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBoulay PLLP
CEOBrian F. Sullivan
Emplyoees45
Last AuditUQ
CIK0001603454
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address16305 36th Avenue North
Suite 100
Minneapolis, MN 55446
Websitehttps://www.celcuity.com
Facsimile-
Telephone+1 763 392-0767
Emailbsullivan@celcuity.com


Your Recent History
NASDAQ
CELC
Celcuity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.